As of December 21, 2020, DCprime completed the merger with Immunicum AB,
to form a leader in the field of allogeneic dendritic cell biology.
Based in Sweden and the Netherlands, Immunicum is publicly traded on the Nasdaq Stockholm.
Please follow this link for Immunicum’s website, or you will be redirected in 30 seconds.